Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial
about
Sodium-glucose cotransporter 2 inhibition: cardioprotection by treating diabetes-a translational viewpoint explaining its potential salutary effectsHeart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiologyIs there an association between low dose aspirin and anemia (without overt bleeding)? Narrative review.Anemia and heart failure: a cause of progression or only a consequence?Anemia and hemoglobin serum levels are associated with exercise capacity and quality of life in chronic obstructive pulmonary disease.Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure.Prevalence of anaemia among patients with heart failure at the Brazzaville University HospitalChanges in blood hemoglobin and blood gases PaO2 and PaCO2 in severe COPD overa three-year telemonitored program of long-term oxygen treatment.Anaemia and the heart.Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance).A U-shaped relationship between haematocrit and mortality in a large prospective cohort study.Anemia does not predict mortality in elderly patients with heart failure.Anemia and heart failure: a community study.Atrial natriuretic peptide and related peptides.Dilated cardiomyopathy: an anaesthetic challenge.Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVD.Association of hemoglobin with ankle-brachial index in general population.Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?Chronic kidney disease, heart failure and anemiaThe prognostic value of anemia in patients with diastolic heart failure.Prevalence of anemia in heart failure and its effects on prognosis.Overview of emerging pharmacotherapy in chronic heart failure.Biomarkers for chronic heart failure : diagnostic, prognostic, and therapeutic challenges.Anemia in heart failure: an overview of current concepts.Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches.Cardiorenal syndrome: an unsolved clinical problem.Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis.The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.Prevalence of anemia and iron deficiency in older Portuguese adults: An EMPIRE substudy.Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.Anaemia is associated with shorter leucocyte telomere length in patients with chronic heart failure.Anaemia in the elderly.Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.Anemia and early mortality in patients with decompensation of chronic heart failure.The impact of age on clinical outcomes following cardiac resynchronisation therapy.Prevalence, Comorbidity and Investigation of Anemia in the Primary Care Office.Effect of ferric carboxymaltose on hospitalization and mortality outcomes in chronic heart failure: A meta-analysis.Clinical predictors of sleep apnoea in heart failure outpatients.The effect of administering erythropoiesis-stimulating proteins in patients with chronic heart failure: results from a retrospective study.Association of admission and discharge anemia status with outcomes in patients hospitalized for acute decompensated heart failure: Differences between patients with preserved and reduced ejection fraction.
P2860
Q28072765-2C7BEA41-538E-4679-A7F0-2E357A946C5EQ30483582-0F8E1267-4F21-4AC2-AE82-F059FD7A3D78Q33709834-ECB2C25A-8E8B-4A9A-B016-411F79CFA7EEQ35252704-CA6A56E7-22D9-4E48-BCB4-E41EE4489D23Q35589333-32476D1B-B710-4FBE-8810-6355F7553A70Q35772087-D839673C-0699-43A5-AFF4-61A9ED8431D8Q35962136-A63D7AFF-0F91-4A13-88C0-23B24EA2D90FQ36217818-4CA45744-F2F5-4E32-B6FD-4A1CAA77FFBDQ36310888-5A11AF38-6473-4610-B496-D8B0581F4006Q36412620-C532B041-5544-4B1F-AC79-252671D41616Q36749452-5CA87C1C-99FE-4EBA-BB2B-C7C99F1C55AAQ36767728-A906A871-3318-4FC4-AA6D-9FC74B5BE0E4Q36882168-6006D4B7-6217-499D-B401-CC348BD238A2Q36896608-EBDC4CFD-0368-41B4-A485-7CE881A39BF5Q37002177-48E42E08-4A6C-42B1-A657-CBC991454DC7Q37073583-767D0184-C501-4398-8556-CD45B0CF1E72Q37097855-6BFCD8F1-C75D-4AAB-9361-8799018408ABQ37138777-AA429C2B-342E-4EA9-B4CF-AD6855B108CFQ37217352-3E609F27-4998-412B-83D2-6B857ECC2002Q37227861-81D5B2B9-B172-4022-9677-65F116D904A6Q37390743-48F3A5FB-01B2-4C9C-A3AE-0B487574AF3FQ37552943-2EFF3497-CE85-4F31-840D-C232E5EB3129Q37660174-E4896CC3-3AA4-4EE5-B248-836F10F3BC44Q37822727-A92B915C-47E3-47F7-9EEE-30F06CCA6E5CQ37883005-8113106A-AAFC-4D5D-A03B-8927A3364B7AQ37887519-1CF0B903-8247-4510-84D7-39DB762DC02BQ37986258-AE424EFC-54C9-477C-9CE5-10CEC00525A0Q40323189-AE0C80C1-27F8-4294-874A-9C70AD65DFF8Q40339822-19C8B4A7-2071-4020-97EA-F798CBE33711Q41686228-63A2318E-725E-4560-BF5C-A084D378E281Q43119689-1EEFC344-F38E-41E0-8182-E87A0E5308C9Q43265727-B97F70B2-4C05-40AD-9B6E-2343DFE8EE44Q43773570-0D52355D-E840-4E71-ADB8-7AFF70F9DADCQ45291209-4BCB91AE-13D3-44E9-AAF1-20CB1BA5F65DQ45335376-18AB1DF4-BBD9-41F0-96E5-620B96604685Q46844132-98D98AC5-B689-44A7-AC12-59D569DDB088Q47415877-AC346DEF-2867-4244-B8DA-FEBD5AAFC5F1Q48085512-911E2599-D0ED-4171-B449-8F68580FA981Q48337206-5ABECABA-3710-4E8B-A7E3-F98027477B41Q50209292-8D47622E-DF70-409F-A0F0-F9F076B09F65
P2860
Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Haemoglobin predicts survival ...... substudy of the ELITE II trial
@ast
Haemoglobin predicts survival ...... substudy of the ELITE II trial
@en
Haemoglobin predicts survival ...... substudy of the ELITE II trial
@nl
type
label
Haemoglobin predicts survival ...... substudy of the ELITE II trial
@ast
Haemoglobin predicts survival ...... substudy of the ELITE II trial
@en
Haemoglobin predicts survival ...... substudy of the ELITE II trial
@nl
prefLabel
Haemoglobin predicts survival ...... substudy of the ELITE II trial
@ast
Haemoglobin predicts survival ...... substudy of the ELITE II trial
@en
Haemoglobin predicts survival ...... substudy of the ELITE II trial
@nl
P2093
P3181
P1476
Haemoglobin predicts survival ...... substudy of the ELITE II trial
@en
P2093
Andrew J S Coats
Darrel P Francis
Philip A Poole-Wilson
Rakesh Sharma
P304
P3181
P356
10.1016/J.EHJ.2004.04.023
P407
P577
2004-06-01T00:00:00Z